Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rapid Protection of the Gastroduodenal Mucosa Against Aspirin-Induced Damage by Rabeprazole

NCT00220857 is registered in ClinicalTrials.gov with Temple University as lead sponsor.

NCT NCT00220857
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00220857 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rapid Protection of the Gastroduodenal Mucosa Against Aspirin-Induced Damage by Rabeprazole
Lead sponsor
Temple University
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2005
Completion date
September 30, 2007
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

normal subjects